If you made any changes in Pure these will be visible here soon.

Research Output 1996 2019

Filter
Review article
2019

Chemically engineered glycan-modified cancer vaccines to mobilize skin dendritic cells

Duinkerken, S., Li, RJE., van Haften, F. J., de Gruijl, TD., Chiodo, F., Schetters, STT. & van Kooyk, Y., 1 Dec 2019, In : Current Opinion Chemical Biology. 53, p. 167-172 6 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium

Amaria, R. N., Menzies, A. M., Burton, E. M., Scolyer, R. A., Tetzlaff, M. T., Antdbacka, R., Ariyan, C., Bassett, R., Carter, B., Daud, A., Faries, M., Fecher, L. A., Flaherty, K. T., Gershenwald, J. E., Hamid, O., Hong, A., Kirkwood, J. M., Lo, S., Margolin, K., Messina, J. & 64 othersPostow, M. A., Rizos, H., Ross, M. I., Rozeman, E. A., Saw, R. P. M., Sondak, V., Sullivan, R. J., Taube, J. M., Thompson, J. F., van de Wiel, B. A., Eggermont, A. M., Davies, M. A., Andrews, M. C., Berry, D. A., Block, M. S., Boland, G. M., Bollin, K. B., Carlino, M. S., Carvajal, R. D., Cohen, J., Davar, D., Delman, K. A., Dummer, R., Farwell, M. D., Fisher, D. E., Fusi, A., Glitza, I. C., de Gruijl, T. D., Gyorki, D. E., Hauschild, A., Hieken, T. J., Larkin, J., Lawson, D. H., Lebbe, C., Lee, J. E., Lowe, M. C., Luke, J. J., McArthur, G. A., McDermott, D. F., McQuade, J. L., Mitchell, T. C., Petrella, T. M., Prieto, P. A., Puzanov, I., Robert, C., Salama, A. K., Sandhu, S., Schadendorf, D., Shoushtari, A. N., Sosman, J. A., Swetter, S. M., Tanabe, K. K., Turajlic, S., Tyler, D. S., Woodman, S. E., Wright, F. C., Zager, J. S., Ascierto, P. A., Spillane, A. J., van Akkooi, A. C. J., Wargo, J. A., Blank, C. U., Tawbi, H. A. & Long, G. V., 1 Jul 2019, In : The Lancet Oncology. 20, 7, p. e378-e389

Research output: Contribution to journalReview articleAcademicpeer-review

Unlocking the therapeutic potential of primary tumor-draining lymph nodes

Rotman, J., Koster, B. D., Jordanova, E. S., Heeren, A. M. & de Gruijl, T. D., 1 Oct 2019, In : Cancer Immunology, Immunotherapy. 68, 10, p. 1681-1688 8 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access
2018

Positive & negative roles of innate effector cells in controlling cancer progression

Stolk, D., van der Vliet, H. J., de Gruijl, T. D., van Kooyk, Y. & Exley, M. A., 2018, In : Frontiers in Immunology. 9, SEP, 1990.

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access
2017

The rise of allogeneic Natural killer cells as a platform for cancer immunotherapy: Recent innovations and future developments

Veluchamy, J. P., Kok, N., van der Vliet, H. J., Verheul, H. M. W., de Gruijl, T. D. & Spanholtz, J., 31 May 2017, In : Frontiers in Immunology. 8, MAY, 631.

Research output: Contribution to journalReview articleAcademicpeer-review